Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Hauptverfasser: Min-Lan Tsai (Verfasst von), Hsiu-Chen Lin (Verfasst von), Chiung-Hui Yen (Verfasst von), Jung-Tzu Ku (Verfasst von), Shian-Ying Sung (Verfasst von), Hsi Chang (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2022-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...